Titelia

Funds holding Belite Bio Inc

ISIN US07782B1044 · Cayman Islands · LEI 984500BD54036BOEAE79

Fund holders
25
Of which ETFs
6 19 other funds
Value held
62.6M $
FundSharesValueWeight in fund
T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC. 207,86233.1M $0.30 %as of Mar 31, 2026 ↗
ALGER SMALL CAP FOCUS FUND ALGER FUNDS 61,8679.8M $1.25 %as of Apr 30, 2026 ↗
Eventide Healthcare & Life Sciences Fund MUTUAL FUND SERIES TRUST 29,0264.6M $0.29 %as of Mar 31, 2026 ↗
Morgan Stanley Discovery Portfolio Brighthouse Funds Trust I 15,9132.5M $0.23 %as of Mar 31, 2026 ↗
T. Rowe Price Health Sciences Portfolio T. ROWE PRICE EQUITY SERIES, INC. 12,7002M $0.31 %as of Mar 31, 2026 ↗
State Street(R) SPDR(R) Portfolio Emerging Markets ETF SPDR INDEX SHARES FUNDS 12,4562M $0.01 %as of Mar 31, 2026 ↗
Discovery Portfolio MORGAN STANLEY INSTITUTIONAL FUND TRUST 10,8591.7M $0.23 %as of Mar 31, 2026 ↗
Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust 6,7271.3M $0.01 %as of Feb 28, 2026 ↗
Fidelity ZERO International Index Fund Fidelity Concord Street Trust 5,001796K $0.01 %as of Apr 30, 2026 ↗
Health Sciences Trust John Hancock Variable Insurance Trust 4,800765.3K $0.34 %as of Mar 31, 2026 ↗
Fidelity Nasdaq Composite Index ETF Fidelity Commonwealth Trust 3,697703.5K $0.01 %as of Feb 28, 2026 ↗
EQ/T.Rowe Price Health Sciences Portfolio EQ Advisors Trust 3,300526.2K $0.33 %as of Mar 31, 2026 ↗
State Street(R) SPDR(R) S&P(R) China ETF SPDR INDEX SHARES FUNDS 3,192508.9K $0.11 %as of Mar 31, 2026 ↗
Discovery Portfolio MORGAN STANLEY VARIABLE INSURANCE FUND INC. 2,474394.5K $0.23 %as of Mar 31, 2026 ↗
Global Endurance Portfolio MORGAN STANLEY INSTITUTIONAL FUND INC 2,053327.3K $2.11 %as of Mar 31, 2026 ↗
Virtus Biotech Clinical Trials Etf ETFis Series Trust I 1,952310.7K $0.83 %as of Apr 30, 2026 ↗
Fidelity Flex International Index Fund Fidelity Salem Street Trust 1,889300.7K $0.01 %as of Apr 30, 2026 ↗
ActivePassive International Equity ETF Trust for Professional Managers 991188.6K $0.02 %as of Feb 28, 2026 ↗
ULTRACHINA PROFUND ProFunds 956152.2K $0.68 %as of Apr 30, 2026 ↗
ALGER HEALTH SCIENCES FUND ALGER FUNDS 786125.1K $0.21 %as of Apr 30, 2026 ↗
Parametric Tax-Managed Emerging Markets Fund Eaton Vance Series Trust II 781124.5K $0.02 %as of Mar 31, 2026 ↗
ALGER SMALL CAP GROWTH FUND ALGER FUNDS 649103.3K $0.05 %as of Apr 30, 2026 ↗
Alger Small Cap Growth Portfolio ALGER PORTFOLIOS 48978K $0.06 %as of Mar 31, 2026 ↗
ALGER SMALL CAP GROWTH INSTITUTIONAL FUND ALGER INSTITUTIONAL FUNDS 24839.5K $0.06 %as of Apr 30, 2026 ↗
T. Rowe Price Innovation Leaders ETF T. Rowe Price Exchange-Traded Funds, Inc. 11718.7K $0.12 %as of Mar 31, 2026 ↗

Download this table: CSV, JSON

Report an error

The funds most exposed to it

The weight is the share of a fund's net assets. The holders table counts shares; this one measures what the company weighs inside each fund.

FundWeight in fund
Global Endurance Portfolio MORGAN STANLEY INSTITUTIONAL FUND INC 2.11 %as of Mar 31, 2026 ↗
ALGER SMALL CAP FOCUS FUND ALGER FUNDS 1.25 %as of Apr 30, 2026 ↗
Virtus Biotech Clinical Trials Etf ETFis Series Trust I 0.83 %as of Apr 30, 2026 ↗
ULTRACHINA PROFUND ProFunds 0.68 %as of Apr 30, 2026 ↗
Health Sciences Trust John Hancock Variable Insurance Trust 0.34 %as of Mar 31, 2026 ↗
EQ/T.Rowe Price Health Sciences Portfolio EQ Advisors Trust 0.33 %as of Mar 31, 2026 ↗
T. Rowe Price Health Sciences Portfolio T. ROWE PRICE EQUITY SERIES, INC. 0.31 %as of Mar 31, 2026 ↗
T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC. 0.30 %as of Mar 31, 2026 ↗
Eventide Healthcare & Life Sciences Fund MUTUAL FUND SERIES TRUST 0.29 %as of Mar 31, 2026 ↗
Discovery Portfolio MORGAN STANLEY INSTITUTIONAL FUND TRUST 0.23 %as of Mar 31, 2026 ↗

Quarter after quarter

Each SEC quarterly data set, newest first. The change is read against the quarter before it.

QuarterHoldersChangeSharesChange
2026Q225+11390,785+150.3 %
2026Q114+7156,142+432.0 %
2025Q47-229,348-17.4 %
2025Q39+135,531+2.0 %
2025Q28-234,820+9.7 %
2025Q110+231,731+2.0 %
2024Q48031,113+20.3 %
2024Q38+225,854+0.4 %
2024Q26+125,742-0.8 %
2024Q15-125,961+2.6 %
2023Q4625,305

Institutional managers

75 managers declare this company to the SEC (Form 13F); the 25 largest follow.

ManagerSharesValue
Darwin Global Management, Ltd.3,057,412456.1M $as of Mar 31, 2026
Paradigm Biocapital Advisors LP1,114,784177.7M $as of Mar 31, 2026
UBS Group AG768,359122.5M $as of Mar 31, 2026
RTW INVESTMENTS, LP715,332114.1M $as of Mar 31, 2026
MILLENNIUM MANAGEMENT LLC570,08890.9M $as of Mar 31, 2026
Holocene Advisors, LP494,49578.8M $as of Mar 31, 2026
EVENTIDE ASSET MANAGEMENT, LLC357,65057M $as of Mar 31, 2026
DEERFIELD MANAGEMENT COMPANY, L.P.304,01348.5M $as of Mar 31, 2026
PRICE T ROWE ASSOCIATES INC /MD/281,80544.9K $as of Mar 31, 2026
MORGAN STANLEY201,40932.1M $as of Mar 31, 2026
PERCEPTIVE ADVISORS LLC151,97924.2M $as of Mar 31, 2026
Patient Square Capital LP116,68418.6M $as of Mar 31, 2026
Duquesne Family Office LLC106,10016.9K $as of Mar 31, 2026
GOLDMAN SACHS GROUP INC105,50916.8M $as of Mar 31, 2026
MPM BIOIMPACT LLC88,04514M $as of Mar 31, 2026
Affinity Asset Advisors, LLC65,00010.4M $as of Mar 31, 2026
FRED ALGER MANAGEMENT, LLC62,57410M $as of Mar 31, 2026
PFM Health Sciences, LP59,4329.5M $as of Mar 31, 2026
RENAISSANCE TECHNOLOGIES LLC52,0008.3M $as of Mar 31, 2026
Longaeva Partners L.P.33,4925.3M $as of Mar 31, 2026
TD Asset Management Inc33,4105.3M $as of Mar 31, 2026
BNP PARIBAS FINANCIAL MARKETS32,5255.2M $as of Mar 31, 2026
ADAR1 Capital Management, LLC26,8804.3M $as of Mar 31, 2026
Artia Global Partners LP24,9894M $as of Mar 31, 2026
Quadrature Capital Ltd23,7083.8M $as of Mar 31, 2026

Declared shareholders of Belite Bio Inc

1 beneficial ownership filing. These stakes do not add up: an asset manager filing aggregates its own funds, already counted above.

ShareholderDeclared stakeShares
Yu-Hsin Lin 3.10 %1,253,935as of Mar 31, 2026 · SCHEDULE 13G
Cite this page

Titelia. "Funds holding Belite Bio Inc". https://titelia.com/en/stocks/belite-bio-inc-US07782B1044